Spanish medicine maker was rocked earlier this year by allegations of fraud
Ageing is a long-term trend that investors can bank on
UK pharma body criticises maker of Ozempic and Wegovy over failure to report £7.8mn in transfers of value
New compound increases strength of antidote for fentanyl and other lethal drugs
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
New drug Kisunla will be 20% more than rival as drugmaker claims it requires fewer treatments
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
Sale of most of FairJourney Biologics means London-based owner GHO Capital realises close to 10-fold return
Members of OxyContin maker’s founding family had fought to uphold protections in $6bn opioid settlement
Information about patients remains ‘liquid gold’ when it comes to enriching medical research
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Discovery could allow more precise and efficient targeting of DNA modifications
Consumer health company spun out of GSK focusing on higher-growth areas such as toothpaste
Danish maker of Wegovy has little competition in the country and massive demand that it can take advantage of
Move opens market with growing rates of obesity to Danish group’s blockbuster drug
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand
Oral formulation offers prospect of cheaper and more convenient access to drug, research suggests
Vutrisiran injection cut risk of death and adverse cardiovascular events by at least 28%, company says
Shares of biotech Sarepta soar 40% after approval for most expensive treatment in the world
Shares in cancer-test developer trading in low volumes ahead of spin-off demanded by antitrust regulators
Avid Bioservices made a blunder
Critics of plan include green activists, farmers, biotech start-ups and multinationals
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
Alcohol, food, tobacco and fossil fuel sectors oppose efforts to target conditions linked to 2.7mn deaths a year, warns WHO
UK Edition
